Spierings explains why the placebo effect makes skincare hard to study, in a clip from the show's full collagen peptides episode.
Recap by typeshit. Post by @science_vs on Instagram.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
Research presented at the anesthesiology meeting linked GLP-1 use with lower odds of heart attack and other heart problems. It shows an association, not proof of cause.
The fitness centre says it knows about reports of peptides being sold or promoted inside the gym and makes clear that isn't allowed.
Nurturher Aesthetics explains why most providers aren't using retatrutide, pointing out that the Lilly drug has no FDA approval yet.
Loading…